Consolidated Statement Of Income

K Pharma,Inc. - Filing #7538109

Concept 2023-01-01 to
2023-09-30
Consolidated statement of income
Statement of income
Net sales
1,000,000,000 JPY
Cost of sales
90,000,000 JPY
Operating expenses
Selling, general and administrative expenses
394,163,000 JPY
Operating expenses
Gross profit (loss)
910,000,000 JPY
Operating profit (loss)
515,836,000 JPY
Ordinary profit (loss)
508,569,000 JPY
Net sales
Selling, general and administrative expenses
Non-operating income
16,000 JPY
Interest income
16,000 JPY
Cost of sales
Non-operating income
Extraordinary losses
36,497,000 JPY
Impairment losses
36,497,000 JPY
Non-operating expenses
Other
90,000 JPY
Non-operating expenses
7,283,000 JPY
Share issuance costs
3,193,000 JPY
Profit (loss) before income taxes
472,072,000 JPY
Gross profit
Income taxes - current
73,859,000 JPY
Extraordinary losses
Income taxes
73,859,000 JPY
Profit (loss)
398,213,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.